24906ad38e3cf35c2fe383a35d58b7dc

BD PHARMINGEN™ PE-CY™7 MOUSE ANTI-HUMAN CD95

BECTON DICKINSON DE COLOMBIA LTDA·Colombia INVIMA·Expires August 25, 2033

Device classification

Product type (Spanish): REACTIVOS IN VITRO
Product type (English): REACTIVOS IN VITRO

Registration information

Analysis ID: 24906ad38e3cf35c2fe383a35d58b7dc
Expire date: August 25, 2033

Authorized company / Fabricante

Name (Spanish): BECTON DICKINSON DE COLOMBIA LTDA
Name (English): BECTON DICKINSON DE COLOMBIA LTDA

Product use / Uso del Producto

Spanish

ANTICUERPOS MONOCLONALES QUE DETECTAN _x000D_ ANTÍGENOS HUMANOS EN CÉLULAS SANGUÍNEAS _x000D_ ASOCIADAS A PATOLOGÍAS ONCOLÓGICAS.

English

MONOCLONAL ANTIBODIES THAT DETECT _x000D_ HUMAN ANTIGENS ON BLOOD CELLS _x000D_ ASSOCIATED WITH ONCOLOGICAL PATHOLOGIES.

About this record

Access comprehensive regulatory information for BD PHARMINGEN™ PE-CY™7 MOUSE ANTI-HUMAN CD95 (BD PHARMINGEN™ PE-CY™7 MOUSE ANTI-HUMAN CD95) in the Colombia medical device market through Pure Global AI's free database. This medical device is registered under INVIMA analysis ID 24906ad38e3cf35c2fe383a35d58b7dc and manufactured by BECTON DICKINSON DE COLOMBIA LTDA. The device was registered on August 25, 2033.

This page provides complete registration details including product type (REACTIVOS IN VITRO), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.